Oaktree Acquisition Corp. III Life Sciences
OACCW- Exchange
- Nasdaq
- Industry
- Blank Checks
- SEC CIK
- 0002029769
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders were filed in the last 90 days; 29 institutions reported holding it in 13F filings for Q2 2026, worth $2.65M in total; no superinvestor holds it.
Key figures
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +3 vs. previous quarter
- 29
- 13F valueReported value at the end of Q2 2026
- $2.65M
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Superinvestors holding OACCW, Q2 2026
No superinvestor reported holding OACCW at the end of Q2 2026.
Latest insider trades
Open-market purchases and sales by Oaktree Acquisition Corp. III Life Sciences insiders from Form 4, newest first.
No open-market purchases or sales by Oaktree Acquisition Corp. III Life Sciences insiders are on file.
Top 10 13F holders, Q2 2026
The largest institutional positions in Oaktree Acquisition Corp. III Life Sciences at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Healthcare of Ontario Pension Plan Trust Fund | 340,000 | $323.0K | 0.00% | 00.0% | Unchanged |
| CNH Partners LLC | 282,120 | $251.1K | 0.00% | 00.0% | Unchanged |
| Toronto Dominion Bank | 189,816 | $178.6K | 0.00% | +16,616+9.6% | Added |
| Walleye Capital LLC | 169,502 | $159.6K | 0.00% | 00.0% | Unchanged |
| Decagon Asset Management LLP | 162,702 | $153.2K | 0.03% | 00.0% | Unchanged |
| Weiss Asset Management LP | 144,767 | $137.5K | 0.00% | 00.0% | Unchanged |
| Boussard & Gavaudan Gestion SAS | 150,000 | $133.5K | 0.01% | +150,000 | New |
| JPMorgan Chase & Co | – | $129.1K | 0.00% | – | – |
| Linden Advisors LP | 120,000 | $126.6K | 0.00% | 00.0% | Unchanged |
| BNP Paribas Arbitrage, SA | 105,907 | $99.7K | 0.00% | 00.0% | Unchanged |